Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Tracking expenses helps young adults see where money goes, identify unwanted habits, and start building a stronger financial foundation from day one.
21,975 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Sweetgreen faced a sharp stock drop this week as traffic and cost pressures weighed on its growth story. This guide b...
As defense spending surging reshapes markets, two ETFs—MISL and ITA—offer different paths to ride the trend. This gui...
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
A major funding milestone puts Canton Network at the center of a new era for crypto infrastructure. Digital Asset is ...
Starboard Value disclosed a dramatic reshuffle in its Q1 2026 13F, exiting Salesforce and Autodesk and plowing into L...
Medicare’s IRMAA brackets changed for 2026, reshaping premium surcharges for higher earners. The two-year lookback us...
A widely shared warning about a gas pump screw scam captured attention, then faded. This article explains what happen...
Lawmakers push a federal framework for digital assets to reduce regulatory fragmentation. The Digital Asset Market Cl...
A Magnite insider disclosed a sizable open-market sale, sparking questions for investors. This guide breaks down what...
Investors are weighing a 32% drop in Netflix stock since April after Reed Hastings signaled a board exit. Here’s how ...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...